Biodexa Pharmaceuticals PLC
NASDAQ:BDRX
Income Statement
Earnings Waterfall
Biodexa Pharmaceuticals PLC
Income Statement
Biodexa Pharmaceuticals PLC
| Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
1
-24%
|
0
-28%
|
0
-78%
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(10)
|
(10)
|
(8)
|
(8)
|
(9)
|
(9)
|
|
| Selling, General & Administrative |
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Research & Development |
(5)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(9)
N/A
|
(9)
-5%
|
(8)
+15%
|
(8)
+0%
|
(9)
-15%
|
(9)
+2%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
0
|
0
|
1
|
1
|
3
|
3
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(8)
N/A
|
(9)
-5%
|
(7)
+16%
|
(7)
+6%
|
(6)
+15%
|
(7)
-9%
|
|
| Net Income | |||||||
| Tax Provision |
1
|
1
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(8)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
|
| Net Income (Common) |
(8)
N/A
|
(8)
-7%
|
(7)
+13%
|
(7)
+4%
|
(6)
+16%
|
(6)
-9%
|
|
| EPS (Diluted) |
-15.49
N/A
|
-0.82
+95%
|
-0.22
+73%
|
-0.51
-132%
|
-0.01
+98%
|
-0.01
N/A
|
|